Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE study (Q82826313)
Jump to navigation
Jump to search
scientific article published on 13 December 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE study |
scientific article published on 13 December 2010 |
Statements
Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE study (English)
Reinier O Schlingemann
Jean-François Korobelnik
Bora Eldem
Ruth Axer-Siegel
Peter Wiedemann
Margarita Gekkieva
Andreas Weichselberger
EXCITE Study Group
13 December 2010